Search Results

Displaying Results 1-1 of 1 "'LYEL'"

Dec 19, 2025, 07:44 ET Immunotherapies Replacing Chemotherapy as Blood Cancer Market to Hit $13B by 2030

(NASDAQ: REGN), Genmab A/S (NASDAQ: GMAB), Autolus Therapeutics plc (NASDAQ: AUTL), and Lyell Immunopharma, Inc. (NASDAQ: LYEL).

More news about: USA News Group


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.